BioLife Sciences Inc. (BLFE)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 66.64 Thousand USD | 0.0% |
| 2017 | 66.64 Thousand USD | 28.96% |
| 2016 | 51.67 Thousand USD | 0.0% |
| 2015 | 51.67 Thousand USD | 0.0% |
| 2007 | 205.74 Thousand USD | -90.11% |
| 2006 | 2.08 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 Q1 | 10.62 USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | -100.0% |
| 2018 FY | 66.64 Thousand USD | 0.0% |
| 2017 FY | 66.64 Thousand USD | 28.96% |
| 2016 FY | 51.67 Thousand USD | 0.0% |
| 2015 FY | 51.67 Thousand USD | 0.0% |
| 2008 Q2 | 421.42 Thousand USD | 145.93% |
| 2008 Q1 | 171.36 Thousand USD | -16.71% |
| 2007 Q2 | 2.51 Million USD | 10.12% |
| 2007 Q1 | 2.28 Million USD | 9.88% |
| 2007 FY | 205.74 Thousand USD | -90.11% |
| 2007 Q3 | 379.46 Thousand USD | -84.93% |
| 2007 Q4 | 205.74 Thousand USD | -45.78% |
| 2006 Q3 | 303.94 Thousand USD | 45.13% |
| 2006 Q4 | 2.08 Million USD | 584.77% |
| 2006 Q2 | 209.43 Thousand USD | 103.83% |
| 2006 Q1 | 102.74 Thousand USD | 0.0% |
| 2006 FY | 2.08 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | NaN% |
| Ansell Limited | 705.27 Million USD | 100.0% |
| Ansell Limited | 706.6 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 22.41 Million USD | 100.0% |
| CB Scientific, Inc. | - USD | NaN% |
| Psykey, Inc. | 625 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.22 Billion USD | 100.0% |
| Encision Inc. | 67.33 Thousand USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 382.83 Thousand USD | 100.0% |
| LifePoint, Inc. | 151.73 Thousand USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | - USD | NaN% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 849.37 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 100.0% |
| SheerVision, Inc. | - USD | NaN% |
| United Health Products, Inc. | 48.48 Thousand USD | 100.0% |
| Vasamed, Inc. | 18.95 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 390.44 Thousand USD | 100.0% |